Autoimmunity-driven enzymatic remodeling of the dermal–epidermal junction in bullous pemphigoid and dermatitis herpetiformis

References

• Mahmood T, Haroon TS. Patterns of direct immunofluorescence in sub-epidermal autoimmune bullous diseases of skin in Lahore, Pakistan. J Pak Assoc Dermatol. 2003; 13:67–71.
   Google Scholar
• Mulyowa GK, Jaeger G, Sitaru C, Bröcker EB, Zillikens D, Schmidt E. Scarring autoimmune bullous disease in a Ugandan patient with autoantibodies to BP180, BP230, and laminin 5. J Am Acad Dermatol. 2006; 54 2 Suppl: S43–S46.
   PubMed Web of Science ®Google Scholar
• Lever WF. Pemphigus. Medicine. 1953; 32:1–123.
   PubMed Web of Science ®Google Scholar
• Liu Z. Immunopathology of bullous pemphigoid, an autoimmune and inflammatory skin blistering disease. Keio J Med. 2003; 52 2: 128–133.
   PubMedGoogle Scholar
• Marietta EV, Camilleri MJ, Castro LA, Krause PK, Pittelkow MR, Murray JA. Transglutaminase autoantibodies in dermatitis herpetiformis and celiac sprue. J Invest Dermatol. 2007; 128:332–335.
   PubMed Web of Science ®Google Scholar
• Sárdy M, Kárpáti S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002; 195:747–757.
   PubMed Web of Science ®Google Scholar
• Liu Z, Giudice GJ, Zhou X, Swartz SJ, Troy JL, Fairley JA, Till GO, Diaz LA. A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest. 1997; 100:1256–1263.
   PubMed Web of Science ®Google Scholar
• Nishie W, Sawamura D, Natsuga K, Shinkuma S, Goto M, Shibaki A, Ujiie H, Olasz E, Yancey KB, Shimizu H. A novel humanized neonatal autoimmune blistering skin disease model induced by maternally transferred antibodies. J Immunol. 2009; 183:4088–4093.
   PubMed Web of Science ®Google Scholar
• MacDonald T, Pender SLF. Proteolytic enzymes in inflammatory bowel disease. Inflamm Bowel Dis. 1998; 4:157–164.
   PubMed Web of Science ®Google Scholar
• Duffy MJ. The role of proteolytic enzymes in cancer invasion and metastasis. Clin Exp Metastasis. 1992; 10:145–155.
   PubMed Web of Science ®Google Scholar
• Shimanovich I, Mihai S, Oostingh GJ, Ilenchuk TT, Bröcker EB, Opdenakker G, Zillikens DZ, Sitaru C. Granulocyte-derived elastase and GB are required for dermal–epidermal separation induced by autoantibodies from patients with epidermolysis bullosa acquisita and bullous pemphigoid. J Pathol. 2004; 204:519–527.
   PubMed Web of Science ®Google Scholar
• Liu Z, Shipley JM, Vu TH, Zhou X, Diaz LA, Werb Z, Senior RM. Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med. 1998; 188:475–482.
   PubMed Web of Science ®Google Scholar
• Briggaman RA, Schechter NM, Fraki J, Lazarus GS. Degradation of the epidermal–dermal junction by proteolytic enzymes from human skin and human poly morphonuclear leukocytes. J Exp Med. 1984; 160:1027–1042.
   PubMed Web of Science ®Google Scholar
• Fröhlich E. Proteases in cutaneous malignant melanoma: Relevance as biomarker and therapeutic target. Cell Mol Life Sci. 2010; 67:3947–3960.
   PubMed Web of Science ®Google Scholar
• Zhao M, Trimbeger ME, Li N, Diaz LA, Shapiro SD, Liu Z. Role of FcRs in animal model of autoimmune bullous pemphigoid. J Immunol. 2006; 177:3398–3405.
   PubMed Web of Science ®Google Scholar
• Korkmaz B, Moreau T, Gauthier F. Neutrophil elastase, proteinase 3 and cathepsin G: Physicochemical properties, activity and physiopathological functions. Biochimie. 2008; 90:227–242.
   PubMed Web of Science ®Google Scholar
• Neves JS, Perez SAC, Spencer LA, Melo RCN, Reynolds L, Ghiran I, Mahmudi-Azer S, Odemuyiwa SO, Dvorak AM, Moqbel R, Weller PF. Eosinophil granules function extracellularly as receptor-mediated secretory organelles. Proc Nat Acad Sci. 2008; 105:18478–18483.
   PubMed Web of Science ®Google Scholar
• Kaminska R, Naukkarinen A, Glinski W, Horsmanheimo M, Harvima IT. Mast cells in developing subepidermal bullous diseases: Emphasis on tryptase, chymase and protease inhibitors. Acta Derm Venereol. 1999; 79:351–355.
   PubMed Web of Science ®Google Scholar
• Brown EE, Edberg JC, Kimberly RP. Fc receptor genes and the systemic lupus erythematosus diathesis. Autoimmunity. 2007; 40 8: 567–581.
   PubMed Web of Science ®Google Scholar
• Takai T. Fc receptors: Their diverse functions in immunity and immune disorders. Springer Semin Immunopathol. 2006; 28:303–304.
   PubMed Web of Science ®Google Scholar
• Vidarsson D, Stemerding AM, Stapleton MN, Spliethoff SE, Janssen H, Rebers FE, de Haas M, van de Winkel JG. FcRn: An IgG receptor on phagocytes with a novel role in phagocytosis. Blood. 2006; 108:3573–3579.
   PubMed Web of Science ®Google Scholar
• Fossati G, Bucknall RC, Edwards SW. Fcgamma receptors in autoimmune diseases. Eur J Clin Invest. 2001; 31 9: 821–831.
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F, Ravetch JV. Fcγ receptors as regulators of immune responses. Nat Rev Immunol. 2008; 8:34–47.
   PubMed Web of Science ®Google Scholar
• Kono H, Kyogoku C, Suzuki T, Tsuchyia N, Honda H, Yamamoto K, Tokunaga K, Honda ZI. FcγRIIB Ile232Thr transmembrane polymorphism associated with human systemic lupus erythematosus decreases affinity to lipid rafts and attenuates inhibitory effects on B cell receptor signaling. Hum Mol Genet. 2005; 14:2881–2892.
   PubMed Web of Science ®Google Scholar
• Wu J, Edberg JC, Redecha PB, Bansal V, Guyre PM, Coleman K, Salmon JE, Kimberly RP. A novel polymorphism of FcγrIIIa (CD16) alters receptor function and predisposes to autoimmune disease. J Clin Invest. 1997; 100:1059–1070.
   PubMed Web of Science ®Google Scholar
• Thabet MM, Huizinga TW, Marques RB, Stoeken-Rijsbergen G, Bakker AM, Kurreeman FA, White SJ, Toes RE. van der Helm-van Mil AH. Contribution of FcγRIIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis. Ann Rheum Dis. 2009; 68:1775–1780.
   PubMed Web of Science ®Google Scholar
• Guilabert A, Lozano F, Iranzo P, Julià M, Suárez-Casasús B, Moreno N, Herrero-Gonzalez J, Mascaró JM. The role of Fc gamma receptors polymorphisms in bullous pemphigoid. J Am Acad Dermatol. 2010; 63 1: 161–163.
   PubMed Web of Science ®Google Scholar
• Nestor MS, Cochran AJ, Ahmed AR. Mononuclear cell infiltrates in bullous disease. J Invest Dermatol. 1987; 88:172–175.
   PubMed Web of Science ®Google Scholar
• Kasperkiewicz M, Zillikens D. The pathophysiology of bullous pemphigoid. Clin Rev Allergy Immunol. 2007; 33:67–77.
   PubMed Web of Science ®Google Scholar
• Caproni M, Feliciani C, Fuligni A, Salvatore E, Atani L, Bianchi B, Pour SM, Proietto G, Toto P, Coscione G, Amerio P, Fabbri P. Th2-like cytokine activity in dermatitis herpetiformis. Br J Dermatol. 1998; 138:242–247.
   PubMed Web of Science ®Google Scholar
• Niimi Y, Pawankar R, Kawana S. Increased expression of matrix metalloproteinase-2, matrix metalloproteinase-9 and matrix metalloproteinase-13 in lesional skin of bullous pemphigoid. Int Arch Allergy Immunol. 2006; 139:104–113.
   PubMed Web of Science ®Google Scholar
• Wiedow O, Meyer-Hoffert U. Neutrophil serine proteases: Potential key regulators of cell signalling during inflammation. J Intern Med. 2005; 257:319–328.
   PubMed Web of Science ®Google Scholar
• Bank U, Ansorge S. More than destructive: Neutrophil-derived serine proteases in cytokine bioactivity control. J Leukoc Biol. 2001; 69:197–206.
   PubMed Web of Science ®Google Scholar
• Mariotti A, Kedeshian PA, Dans M, Curotola AM, Gagnoux-Palacios L, Giancotti FG. EGFR signaling through Fyn kinase disrupts the function of integrin α6β4 at hemidesmosomes: Role in epithelial cell migration and carcinoma invasion. J Cell Biol. 2001; 155:447–458.
   PubMed Web of Science ®Google Scholar
• Schmidt E, Reimer S, Kruse N, Jainta S, Bröcker EB, Marinkovich MP, Giudice GJ, Zillikens D. Autoantibodies to BP180 associated to bullous pemphigoid release interleukin-6 and interleukin-8 from cultured human keratinocytes. J Invest Dermatol. 2000; 115:842–848.
   PubMed Web of Science ®Google Scholar
• Hendrix JD, Mangnum KL, Zone JJ, Gammon R. Cutaneous IgA deposits in bullous diseases function as ligands to mediate adherence of activated neutrophils. J Invest Dermatol. 1990; 94:667–672.
   PubMed Web of Science ®Google Scholar
• Oikarinen AI, Zone JJ, Ahmed AR, Kiistala U, Uitto J. Demonstration of collagenase and elastase activities in the blister fluids from bullous skin diseases. Comparison between dermatitis herpetiformis and bullous pemphigoid. J Invest Dermatol. 1983; 81:261–266.
   PubMed Web of Science ®Google Scholar
• Bowszyc-Dmochowska M, Dmochowski M. Immediate hypersensitivity phenomena in bullous pemphigoid: Critical concepts. J Med. 2002; 33:189–198.
   PubMedGoogle Scholar
• Dmochowski M, Gornowicz J, Seraszek A, Kaczmarek E, Bowszyc-Dmochowska M. Neutrophil elastase, eosinophil major basic protein and autoantibodies to BP230 in human bullous pemphigoid lesions JC Bystryn Pemphigus & Pemphigoid Meeting: From the Bench to the Bedside; 2010 Nov 5–6; Bethesda, USA. Program/Abstracts 2010. p 11.
   Google Scholar
• Frezzolini A, Teofoli P, Cianchini G, Barduagni S, Ruffelli M, Ferranti G, Puddu P, De Pita O. Increased expression of eotaxin and its specific receptor CCR3 in bullous pemphigoid. Eur J Dermatol. 2002; 12 1: 27–31.
   PubMed Web of Science ®Google Scholar
• Chen R, Ning G, Zhao ML, Fleming MG, Diaz LA, Werb Z, Liu Z. Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest. 2001; 108 8: 1151–1158.
   PubMed Web of Science ®Google Scholar
• Kasahara-Imamura M, Hosokawa H, Maekawa N, Horio T. Activation of Fc epsilon RI-positive eosinophils in bullous pemphigoid. Int J Mol Med. 2001; 7 3: 249–253.
   PubMed Web of Science ®Google Scholar
• Cugno M, Tedeschi A, Asero R, Meroni PL, Marzano AV. Skin autoimmunity and blood coagulation. Autoimmunity. 2010; 43 2: 189–194.
   PubMed Web of Science ®Google Scholar
• Verraes S, Hornebeck W, Polette M, Borradori L, Bernard P. Respective contribution of neutrophil elastase and matrix metalloproteinase 9 in the degradation of BP180 (type XVII collagen) in human bullous pemphigoid. J Invest Dermatol. 2001; 117:1091–1096.
   PubMed Web of Science ®Google Scholar
• Zebrowska A, Narbutt J, Sysa-Jedrzejowska A, Kobos J, Waszczykowska E. The imbalance between metalloproteinases and their tissue inhibitors is involved in the pathogenesis of dermatitis herpetiformis. Mediators Inflamm. 2005; 6:373–379.
   Google Scholar
• Bowszyc-Dmochowska M, Seraszek A, Kaczmarek E, Gornowicz J, Dmochowski M. Low strength of correlation between the intensity of neutrophil elastase expression in lesional skin and the level of serum IgA antibodies to epidermal transglutaminase in dermatitis herpetiformis. Open Autoimmun J. 2009; 1:1–4.
   Google Scholar
• Reunala T. Dermatitis herpetiformis. Clin Dermatol. 2001; 19:728–736.
   PubMed Web of Science ®Google Scholar
• Alexander JO. Is eosinophilia of diagnostic importance in dermatitis herpetiformis?. Br J Dermatol. 1961; 73:267–272.
   PubMed Web of Science ®Google Scholar
• Caproni M, Cardinali C, D'Agata A, Selvaggi W, Fabbri P. Serum eosinophil cationic protein, myeloperoxidase, tryptase, eotaxin and Th2-like cytokines in dermatitis herpetiformis. Int Arch Allergy Immunol. 2002; 128:67–72.
   PubMed Web of Science ®Google Scholar
• Morton HC, Brandtzaeg P. CD89: The human myeloid IgA Fc receptor. Arch Immunol Ther Exp. 2001; 49:217–229.
   PubMed Web of Science ®Google Scholar
• Gornowicz J, Bowszyc-Dmochowska M, Dmochowski M. Eosinophil-derived neurotoxin (EDN) in relation to IgA autoantibodies to epidermal transglutaminase in dermatitis herpetiformis. Clin Dermatol. 2009; 11:13–15.
   Google Scholar
• Dmochowski M, Gornowicz J, Seraszek A, Kaczmarek E, Bowszyc-Dmochowska M. Cutaneous expression of neutrophil elastase in relation to IgA autoantibodis to nonapeptides of gliadin and tissue transglutaminase in dermatitis herpetiformis. J Invest Dermatol. 2011; 131 1 Suppl: S2.
   Google Scholar
• Wolnik-Trzeciak G, Bowszyc-Dmochowska M, Górna A, Nieruchalska E, Kaczmarek E, Dmochowski M. Eosinophil major basic protein (MBP) in relation to IgA antibodies to epidermal transglutaminase in dermatitis herpetiformis. Clin Dermatol. 2005; 7:67–71.
   Google Scholar
• Salmela MT, Pender SLF, Reunala T, MacDonald T, Saarialho-Kere U. Parallel expression of macrophage metalloelastase (MMP-12) in duodenal and skin lesions of patients with dermatitis herpetiformis. Gut. 2001; 48:496–502.
   PubMed Web of Science ®Google Scholar
• Liu Z, Shapiro SD, Zhou X, Twining SS, Senior RM, Giudice GJ, Fairley JA, Diaz LA. Neutrophil elastase plays a critical role in experimental bullous pemphigoid. J Clin Invest. 2000; 105:113–123.
   PubMed Web of Science ®Google Scholar
• Liu Z, Zhou X, Shapiro SD, Shipley JM, Twining SS, Diaz LA, Senior RM, Werb Z. The serpin α1-proteinase inhibitor is a critical substrate for gelatinase B/MMP9 in vivo. Cell. 2000; 102:647–655.
   PubMed Web of Science ®Google Scholar
• Pehamberger H, Gschnait F, Konrad K, Holubar K. Bullous pemphigoid, herpes gestationis and linear dermatitis herpetiformis: Circulating anti-basement membrane zone antibodies; in vitro studies. J Invest Dermatol. 1980; 74:105–108.
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Inoue N, Masada R, Fujimori A, Saito T, Imajoh-Ohmi S, Shinkai H, Sakiyama H. Cloning of hamster type XVII collagen cDNA, and pathogenesis of anti-type XVII collagen antibody and complement in hamster bullous pemphigoid. J Invest Dermatol. 2002; 118:485–492.
   PubMed Web of Science ®Google Scholar
• Hartenstein B, Dittrich BT, Stickens D, Heyer B, Vu TH, Teurich S, Schropp-Kistner M, Werb Z, Angel P. Epidermal development and wound healing in matrix metalloproteinase 13-deficient mice. J Invest Dermatol. 2006; 126:486–496.
   PubMed Web of Science ®Google Scholar
• Zone JJ, Egan CA, Taylor TB, Meyer LJ. IgA autoimmune disorders: Development of a passive transfer mouse model. J Investig Dermatol Symp Proc. 2004; 9:47–51.
   PubMedGoogle Scholar
• Zone JJ, Schmidt L, Sotiriou M, Taylor T, Hull CM, Meyer LJ. Deposition of granular immunoglobulin in dermal papillae of human skin by passive transfer of anti-epidermal transglutaminase antibody to SCID mice bearing normal human skin. J Invest Dermatol. 2009; 129:S135.
   Web of Science ®Google Scholar
• Zone JJ, Schmidt L, Taylor T, Hull CM, Sotiriou M, Jaskowski TD, Hill HR, Meyer LJ. Dermatitis herpetiformis sera or goat anti-transglutaminase-3 transferred to human skin-grafted mice mimics dermatitis herpetiformis immunopathology. J Immunol. 2011; 186:4474–4480.
   PubMed Web of Science ®Google Scholar
• Nimmerjahn F. Activating and inhibitory FcgammaRs in autoimmune disorders. Springer Semin Immunopathol. 2006; 28:305–319.
   PubMed Web of Science ®Google Scholar
• Yu X, Holdorf K, Kasper B, Zillikens D, Ludwig RJ, Peterson F. Fc gammaRIIA and FcgammaRIIIB are required for autoantibody-induced tissue damage in experimental human models of bullous pemphigoid. J Invest Dermatol. 2010; 130:2841–2844.
   PubMed Web of Science ®Google Scholar
• Weisenseel P, Martin S, Partscht K, Messer G, Prinz JC. Relevance of the low-affinity type of the Fcgamma-receptorIIIA-polymorphism in bullous pemphigoid. Arch Dermatol Res. 2007; 299:163–164.
   PubMed Web of Science ®Google Scholar
• Trevani AS, Andonegui A, Isturiz MA, Schatner M, Serebrinsky G, Geffner JR. Effect of proteolytic enzymes on neutrophil FcgammaRII activity. Immunology. 1994; 82:632–637.
   PubMed Web of Science ®Google Scholar
• Fairley JA, Burnett CT, Fu CL, Larson DL, Fleming MG, Giudice GJ. A pathogenic role for IgE in autoimmunity: Bullous pemphigoid IgE reproduces the early phase of lesion development in human skin grafted to nu/nu mice. J Invest Dermatol. 2007; 127:2605–2611.
   PubMed Web of Science ®Google Scholar
• Gomes M, Herr AB. IgA and IgA-specific receptors in human disease: Structural and functional insights into pathogenesis and therapeutic potential. Springer Semin Immunopathol. 2006; 28:383–395.
   PubMed Web of Science ®Google Scholar
• Wines BD, Hogarth PM. IgA receptors in health and disease. Tissue Antigens. 2006; 6:103–114.
   Google Scholar
• Grando SA, Glukhenky BT, Drannik GN, Kostromin AP, Boiko YYA, Senyuk OF. Autoreactive cytotoxic T lymphocytes in pemphigus and pemphigoid. Autoimmunity. 1989; 3:247–260.
   PubMed Web of Science ®Google Scholar